Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)

BACKGROUND: To compare survival outcomes of patients with advanced or metastatic non‐small cell lung cancer (NSCLC) who received immunotherapy as first‐, second‐ or beyond line, versus matched patients receiving standard chemotherapy with special characterization of hyperprogressors. METHODS: A retr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Ruiz‐Patiño, Alejandro, Arrieta, Oscar, Cardona, Andrés F., Martín, Claudio, Raez, Luis E., Zatarain‐Barrón, Zyanya L., Barrón, Feliciano, Ricaurte, Luisa, Bravo‐Garzón, María A., Mas, Luis, Corrales, Luis, Rojas, Leonardo, Lupinacci, Lorena, Perazzo, Florencia, Bas, Carlos, Carranza, Omar, Puparelli, Carmen, Rizzo, Manglio, Ruiz, Rossana, Rolfo, Christian, Archila, Pilar, Rodríguez, July, Sotelo, Carolina, Vargas, Carlos, Carranza, Hernán, Otero, Jorge, Pino, Luis E., Ortíz, Carlos, Laguado, Paola, Rosell, Rafael
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6996989/
https://ncbi.nlm.nih.gov/pubmed/31828967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13272
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados